These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 9196700)
1. Anticoagulants for venous thrombosis. Toh CH Postgrad Med J; 1997 May; 73(859):283-5. PubMed ID: 9196700 [TBL] [Abstract][Full Text] [Related]
2. Management of venous thromboembolism: optimization by clinical trials. Turpie AG Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis. Hirsh J Haemostasis; 1996 Oct; 26 Suppl 4():189-98. PubMed ID: 8979124 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic optimisation of the treatment of deep vein thrombosis. Iorio A; Agnelli G Clin Pharmacokinet; 1997 Feb; 32(2):145-72. PubMed ID: 9068929 [TBL] [Abstract][Full Text] [Related]
6. [Anticoagulant and thrombolytic therapy in deep venous thrombosis and pulmonary embolism]. Nielsen HK; Lassen JF; Ravn HB; Husted SE Ugeskr Laeger; 1995 May; 157(20):2835-40. PubMed ID: 7785097 [TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism. Pineo GF; Hull RD Annu Rev Med; 1997; 48():79-91. PubMed ID: 9046947 [TBL] [Abstract][Full Text] [Related]
8. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes]. MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309 [No Abstract] [Full Text] [Related]
9. Current management of acute symptomatic deep vein thrombosis. Heit JA Am J Cardiovasc Drugs; 2001; 1(1):45-50. PubMed ID: 14728051 [TBL] [Abstract][Full Text] [Related]
14. The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects. Hull RD; Pineo GF; Raskob GE Haemostasis; 1998; 28 Suppl 3():8-16. PubMed ID: 10069757 [TBL] [Abstract][Full Text] [Related]
15. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. van Den Belt AG; Prins MH; Lensing AW; Castro AA; Clark OA; Atallah AN; Burihan E Cochrane Database Syst Rev; 2000; (2):CD001100. PubMed ID: 10796593 [TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin for the prevention and treatment of venous thromboembolism. Raskob GE Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157 [TBL] [Abstract][Full Text] [Related]
20. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group. van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]